BACKGROUND: The treatment of cardiogenic shock (CS) in peripheral hospitals may be challenging when acute mechanical circulatory support (MCS) is not available. Tertiary care centers may provide mobile extracorporeal membrane oxygenation (ECMO) teams to support the treatment of CS-patients externally. METHODS: We retrospectively analyzed our single-center experience with a mobile ECMO team focussing on decision-making and survival data of CS-patients retrieved by ECMO support from peripheral hospitals to our tertiary care center between January 2012 and October 2018. RESULTS: A total number of 134 CS-patients have been retrieved by ECMO support to our center within the observation period. Forty-three (32%) died on the acute MCS device, while 59 (44%) patients could be weaned from the acute MCS. Twenty-nine (22%) were bridged to implantation of a durable MCS system and 6 were finally transplanted. The overall 1-year survival was 33%. Interestingly, advanced patient age did not significantly affect survival. CONCLUSIONS: Acute MCS for CS may be provided by experienced mobile teams allowing for retrieval of patients from peripheral hospitals to tertiary care centers. Relatively low survival rates oppose intensive material and human resources. It is therefore mandatory to constantly refine logistics and selection criteria.
BACKGROUND: The treatment of cardiogenic shock (CS) in peripheral hospitals may be challenging when acute mechanical circulatory support (MCS) is not available. Tertiary care centers may provide mobile extracorporeal membrane oxygenation (ECMO) teams to support the treatment of CS-patients externally. METHODS: We retrospectively analyzed our single-center experience with a mobile ECMO team focussing on decision-making and survival data of CS-patients retrieved by ECMO support from peripheral hospitals to our tertiary care center between January 2012 and October 2018. RESULTS: A total number of 134 CS-patients have been retrieved by ECMO support to our center within the observation period. Forty-three (32%) died on the acute MCS device, while 59 (44%) patients could be weaned from the acute MCS. Twenty-nine (22%) were bridged to implantation of a durable MCS system and 6 were finally transplanted. The overall 1-year survival was 33%. Interestingly, advanced patient age did not significantly affect survival. CONCLUSIONS: Acute MCS for CS may be provided by experienced mobile teams allowing for retrieval of patients from peripheral hospitals to tertiary care centers. Relatively low survival rates oppose intensive material and human resources. It is therefore mandatory to constantly refine logistics and selection criteria.
Entities:
Keywords:
Mechanical circulatory support (MCS); cardiogenic shock (CS); extracorporeal life support (ECLS); extracorporeal membrane oxygenation (ECMO); hub and spoke network
Authors: Sabina P W Guenther; Stefan Buchholz; Frank Born; Stefan Brunner; René Schramm; Dominik J Hoechter; Vera von Dossow; Maximilian Pichlmaier; Christian Hagl; Nawid Khaladj Journal: Air Med J Date: 2017-08-12
Authors: Suzanne de Waha; Tobias Graf; Steffen Desch; Georg Fuernau; Ingo Eitel; Janine Pöss; Alexander Jobs; Thomas Stiermaier; Jakob Ledwoch; Ariane Wiedau; Philipp Lurz; Gerhard Schuler; Holger Thiele Journal: Clin Res Cardiol Date: 2017-01-16 Impact factor: 5.460
Authors: Eduardo Barge-Caballero; Luis Almenar-Bonet; Francisco Gonzalez-Vilchez; José L Lambert-Rodríguez; José González-Costello; Javier Segovia-Cubero; María A Castel-Lavilla; Juan Delgado-Jiménez; Iris P Garrido-Bravo; Diego Rangel-Sousa; Manuel Martínez-Sellés; Luis De la Fuente-Galan; Gregorio Rábago-Juan-Aracil; Marisa Sanz-Julve; Daniela Hervás-Sotomayor; Sonia Mirabet-Pérez; Javier Muñiz; Maria G Crespo-Leiro Journal: Eur J Heart Fail Date: 2017-09-26 Impact factor: 15.534
Authors: Sean van Diepen; Jason N Katz; Nancy M Albert; Timothy D Henry; Alice K Jacobs; Navin K Kapur; Ahmet Kilic; Venu Menon; E Magnus Ohman; Nancy K Sweitzer; Holger Thiele; Jeffrey B Washam; Mauricio G Cohen Journal: Circulation Date: 2017-09-18 Impact factor: 29.690
Authors: Veli-Pekka Harjola; Wilfried Mullens; Marek Banaszewski; Johann Bauersachs; Hans-Peter Brunner-La Rocca; Ovidiu Chioncel; Sean P Collins; Wolfram Doehner; Gerasimos S Filippatos; Andreas J Flammer; Valentin Fuhrmann; Mitja Lainscak; Johan Lassus; Matthieu Legrand; Josep Masip; Christian Mueller; Zoltán Papp; John Parissis; Elke Platz; Alain Rudiger; Frank Ruschitzka; Andreas Schäfer; Petar M Seferovic; Hadi Skouri; Mehmet Birhan Yilmaz; Alexandre Mebazaa Journal: Eur J Heart Fail Date: 2017-05-30 Impact factor: 15.534
Authors: James K Kirklin; David C Naftel; Francis D Pagani; Robert L Kormos; Lynne W Stevenson; Elizabeth D Blume; Susan L Myers; Marissa A Miller; J Timothy Baldwin; James B Young Journal: J Heart Lung Transplant Date: 2015-10-08 Impact factor: 10.247
Authors: Kiran Shekar; Daniel V Mullany; Bruce Thomson; Marc Ziegenfuss; David G Platts; John F Fraser Journal: Crit Care Date: 2014-05-09 Impact factor: 9.097